Covalent fragment approaches targeting non-cysteine residues

Trends Pharmacol Sci. 2023 Nov;44(11):802-816. doi: 10.1016/j.tips.2023.08.014. Epub 2023 Sep 26.

Abstract

Covalent fragment approaches combine advantages of covalent binders and fragment-based drug discovery (FBDD) for target identification and validation. Although early applications focused mostly on cysteine labeling, the chemistries of available warheads that target other orthosteric and allosteric protein nucleophiles has recently been extended. The range of different warheads and labeling chemistries provide unique opportunities for screening and optimizing warheads necessary for targeting non-cysteine residues. In this review, we discuss these recently developed amino-acid-specific and promiscuous warheads, as well as emerging labeling chemistries, which includes novel transition metal catalyzed, photoactive, electroactive, and noncatalytic methodologies. We also highlight recent applications of covalent fragments for the development of molecular glues and proteolysis-targeting chimeras (PROTACs), and their utility in chemical proteomics-based target identification and validation.

Keywords: amino acid labeling; covalent fragment; covalent labeling; covalent warheads; fragment-based drug discovery; photocatalysis.

Publication types

  • Review